102 results
Showing 1–20 · 0.19 seconds · RSS
Frontiers in Drug Delivery
Scopus
ISSN 2674-0850 · Frontiers Media S.A. · 102 articles in the index
-
Journal Article
Advancing transdermal drug delivery through 4D bioprinting and dynamic skin modelling
Transdermal drug delivery (TDD) provides a non-invasive approach for sustained drug release. However, traditional models present limitations in capturing the dynamic interactions between drugs, skin and the environmental factors over time. The incorporation of time as a critical dimension alongside…
-
Journal Article
Local delivery of tranexamic acid for hemorrhage control in trauma: a narrative review
BackgroundUncontrolled hemorrhage, often accompanied by trauma-induced coagulopathy is a leading cause of preventable death, accounting for 30%–40% of trauma fatalities. Tranexamic acid (TXA), an antifibrinolytic agent, has been extensively studied and proven effective when administered…
-
Journal Article
Design and optimization of mucoadhesive chitosan microspheres for oesophageal delivery of fluconazole
BackgroundOesophageal candidiasis remains challenging to treat owing to rapid transit of conventional oral formulations through the oesophagus, resulting in inadequate local drug delivery and reduced therapeutic efficacy. To address these limitations, the present study aimed to develop…
-
Journal Article
Microplastics matter: practical implications of the EU REACH restriction for the pharmaceutical industry
Synthetic polymer microparticles (SPMs), commonly referred to as microplastics, are subject to increasing restrictions due to their environmental persistence and uncertainty about potential human health effects. These substances are regulated under Regulation (EC) No 1907/2006 (REACH). Commission…
-
Journal Article
The fourth controlled release society workshop on oral peptide administration
The Controlled Release Society (CRS, www.controlledrelease.org) held its fourth iteration of research and development in oral peptide administration on 14 July 2025 in Philadelphia (United States), entitled “Recent advances in oral peptide delivery: from molecule to market.” The previous versions…
-
Journal Article
Antiparasitic triterpenic ester and ursolic acid lipid nanocapsule design, cytotoxicity, and permeability evaluation for oral delivery
IntroductionUrsolic acid (UA), the antimalarial triterpenic mixture 8TTE (containing C-27 feruloyl and coumaroyl esters of ursane and oleane skeletons), and the semi-synthetic antitrypanosomal derivative ursolic acid O-phenyl propionate (UAOPP) exhibit high lipophilicity, which may limit their oral…
-
Journal Article
Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications
BackgroundThe symptoms of dry eye disease (DED) result from activation of ocular sensory nerves and constitute the dominant component of its clinical presentation. We assessed the effect of phosphosulindac (PS), a small molecule efficacious in the treatment of DED in preclinical models, on corneal…
-
Journal Article
Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access
Efficient delivery of gene therapy vectors and regenerative cargo to the central nervous system (CNS) is limited by the hyaluronic acid (HA)-rich extracellular matrix (ECM). Adeno-associated virus (AAV) particles, mesenchymal stem cells (MSCs), multilineage-differentiating stress-enduring (MUSE)…
-
Journal Article
A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules
IntroductionOral delivery of peptides is a promising alternative to invasive injectable therapies, offering improved patient adherence and convenience. Glucagon-like peptide-1 (GLP-1) analogs, in particular, are highly effective for the management of type 2 diabetes mellitus and obesity, yet their…
-
Journal Article
Engineering the oxidative myocardium: ROS-responsive biomaterials for precision cardiovascular delivery in ischemia-reperfusion injury and post-infarction remodeling
Myocardial ischemia-reperfusion injury (MIRI) and post-infarction remodeling are characterized by dynamic oxidative stress that varies across myocardial regions and disease stages. Reactive oxygen species (ROS)-responsive and redox-modulating biomaterials seek to exploit this environment through…
-
Journal Article
Engineering a medical device for intranasal immunisation: ensuring targeted delivery and formulation stability
IntroductionThe efficacy of nasal vaccination critically depends on the delivery method, which must ensure precise and reproducible deposition of the vaccine within the nasal cavity to effectively stimulate mucosal immune structures such as the nasal\x{2011}associated lymphoid tissue (NALT)…
-
Journal Article
Harnessing liposomal delivery to boost polyphenols’ potential in chronic wound therapy
IntroductionChronic wounds pose a significant clinical challenge due to impaired healing, persistent inflammation, and susceptibility to infection, often by antimicrobial-resistant bacteria. Therefore, active compounds should ideally act both as antimicrobials with limited potential for resistance…
-
Journal Article
Case report: Caplacizumab without plasma exchange for severe thrombotic thrombocytopenic purpura
A 45-year-old female Jehovah’s Witness presented with transient expressive aphasia, blurred vision, and dizziness for several hours. A complete blood count (CBC) showed anemia (hemoglobin: 6.3 g/dL), thrombocytopenia (platelet count: 21 × 103/µL), and undetectable haptoglobin. The peripheral smear…
-
Journal Article
Synthesis, characterisation, and in vitro assessment of hyaluronic acid-coated solid lipid nanoparticles entrapping dexamethasone palmitate designed for intra-articular administration
Osteoarthritis (OA) is the major cause of pain and disability worldwide, particularly affecting the knee joint. Although intra-articular (IA) treatments including corticosteroids and hyaluronic acid (HA), are commonly used to manage symptoms, their therapeutic effects are often short-lived…
-
Journal Article
The biological memory buffer hypothesis: can programmable nanocarriers shape cellular memory to improve the durability of mRNA vaccines and gene therapies?
IntroductionMessenger RNA vaccines and gene therapies enable rapid and programmable biological intervention, but their therapeutic durability remains variable. Existing nanomedicine research primarily evaluates delivery efficiency, targeting, RNA protection and early protein expression, which do…
-
Journal Article
Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworks
Monoclonal antibodies (mAbs) constitute the most rapidly expanding and therapeutically impactful class of biological medicines, driven by their exceptional target specificity, modular engineering capabilities, predictable pharmacokinetics facilitated by neonatal Fc receptor (FcRn) recycling, and…
-
Journal Article
Nanoparticle-mediated mRNA delivery for cancer, autoimmunity, and genetic diseases: a rapid review
IntroductionMessenger RNA (mRNA) therapeutics have advanced from experimental platforms to clinical application, driven largely by the success of lipid nanoparticle (LNP)-based COVID-19 vaccines. Building on this progress, nanoparticle-mediated mRNA delivery is being extended to non-infectious…
-
Journal Article
Colour of medicines and children’s acceptability: What children think of the colour of oral dosage forms?
BackgroundColour plays an important role in shaping consumer experiences, and in the context of medicines, it may influence patients’ expectations, behaviours, and treatment adherence. There is limited research on how children respond to medicine colour, despite their increased sensitivity to…